WebNov 4, 2024 · PTEN is a dual-specificity protein and lipid phosphatase and a well-established tumour suppressor commonly affected by loss-of-function mutations in many sporadic forms of cancer as well as in the ... WebApr 15, 2024 · At 1 year, while heterozygous loss of Pten alone has a minimal phenotype in the murine prostate (Trotman et al., 2003, Wang et al., 2003), Pb-Cre4;Chd1 f/f;Pten f/+ demonstrated a high penetrance of focal high-grade prostatic intraepithelial neoplasia (HG-PIN) (Figures 1 E and 1F), with high levels of AR and elevated proliferative indices ...
CHD1 chromodomain helicase DNA binding protein 1
WebMay 7, 2024 · Intriguingly, CHD1 is identified as a putative synthetic-essential gene in PTEN-deficient prostate cancer [7]. Mechanistically, PTEN deficiency results in … WebIn Pten and Pten/Smad4 genetically engineered mouse models, prostate-specific deletion of Chd1 resulted in markedly delayed tumor progression and prolonged survival. Chd1 deletion was associated with profound tumor microenvironment (TME) remodeling characterized by reduced myeloid-derived suppressor cells (MDSC) and increased CD8 … cutting facial hair woman
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN ...
WebAug 4, 2024 · In our study, we knocked out CHD1 in the nontumorigenic prostate epithelial cell line, RWPE-1, which is ETS fusion negative, PTEN positive, and highly expresses CHD1. 30,31 Analysis of the CHD1 KO clones showed altered cell adhesion properties and morphology, a reduction in basal pAKT levels, and a reduction in laminin, as compared … WebJul 1, 2024 · Together, this study demonstrated that CHD1 plays important roles in tumor initiation and progression of PTEN-deficient PCa, and presents a promising context-specific therapeutic target in PCa. In addition, the novel approach of “synthetic essentiality” we proposed provides a good tool to identify context-specific therapeutic targets for ... WebMar 30, 2024 · Gupta S, Halabi S, Kemeny G, Anand M, Giannakakou P, Nanus DM, George DJ, Gregory SG, Armstrong AJ. Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer. Mol Cancer Res. 2024 Jun;19(6):1040-1050. doi: 10.1158/1541-7786.MCR-20-0975. … cutting faced insulation